 |
cobitolimod |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-08 00:00:00 |
| Sponsor | InDex Pharmaceuticals AB;23a Tomtebodav�gen;Hagalund |
Related Access Program
| |
cobitolimod |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-08 00:00:00 |
| Sponsor | InDex Pharmaceuticals AB;23a Tomtebodav�gen;Hagalund |